A double-blind study funded by Shire biopharmaceutical company found that one of its products, Vyvanse, could alleviate the symptoms of Attention Deficit Hyperactivity Disorder in children ages six to 12 years old.

Researchers divided a group of 129 children (ages six to 12 years old) with ADHD into two groups. One group received a placebo and the other group took Vyvanse. The children who took the drug had fewer symptoms for up to 12 hours than did the children who took the placebo.

Side effects of the drug are decreased appetite, insomnia, headaches, irritability, upper abdominal pain and affect ability.

The study appeared in the journal Child and Adolescent Psychiatry and Mental Health.

Labels: research, symptoms, drug_study

Posted By: Aspen/CRC